COMP <GO>
HRTX vs CTOR // OPERATING MARGIN
Heron Therapeutics Inc. (NASDAQ) VS. Citius Oncology Inc. (NASDAQ) • 15-METRIC TALLY: HRTX 3
— CTOR 0
■ METRIC PARITY
LAST: $0.30 (+6.27%) • MKT CAP: $52.7M
operating-margins
-1.60%
LAST: $0.59 (+7.24%) • MKT CAP: $51.5M
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HRTX VS. CTOR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HRTX | CTOR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -11.16% | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | -1.60% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -12.90% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | HRTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.6 | 31.0 | +6.60 | HRTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $52.7M | $51.5M | $1.2M | HRTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HRTX REV | CTOR REV | HRTX GROSS % | CTOR GROSS % | HRTX FCF | CTOR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $154.9M | $65.9M | 73.3% | — | -$27.9M | -$5.5M |
| FY 2024 | $144.3M | $57.6M | 73.2% | — | -$24.2M | $126.4K |
| FY 2023 | $309.7M | $2.8M | — | — | -$58.8M | -$601.3K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HRTX // BETA —
CTOR // BETA —